Medical center people
John Huguenard
Laura Attardi
David Relman
Aijaz Ahmed, MD, has been promoted to associate professor of medicine and associate medical director of the adult liver transplant program. His research interests include viral hepatitis and liver transplantation. He has developed clinical expertise in optimizing antiviral therapy in patients with chronic hepatitis C prior to and following liver transplantation.
John Huguenard, PhD, professor of neurology and neurological sciences and, by courtesy, of molecular and cellular physiology, is the recipient of the American Epilepsy Society Epilepsy Research Recognition Award for basic science. The award is given annually to outstanding active scientists and clinicians working in all aspects of epilepsy research. Huguenard's research involves the cellular, physiological and molecular mechanisms underlying neuronal rhythmicity and the origin of epilepsy. He also serves as director of the neuroscience graduate program.
Carlos Milla, MD, has been appointed associate professor of pediatrics, as of Dec. 1. His main area of research centers on the inflammatory responses that lead to airway disease in cystic fibrosis and the metabolic factors that contribute to lung disease progression. Milla has accumulated substantial experience on the study of longitudinal outcomes in cystic fibrosis and is recognized for his contributions in this area. He is also active in quality improvement, identifying and implementing strategies to improve the clinical outcomes of patients with cystic fibrosis.
Theodore Jardetzky, PhD, professor of structural biology, and Gary Schoolnik, MD, professor of infectious diseases and of microbiology and immunology, are among the 38 microbiologists who have been elected to fellowship in the American Academy of Microbiology. Fellows are elected annually through a selective, peer-review process, based on scientific achievement and original contributions that have advanced microbiology. Jardetzky's research focuses on molecular interactions of the immune system, particularly the molecular mechanisms involved in human immunity and disease. Schoolnik's research uses molecular genetic and genomic methods and combines laboratory and field work to study infectious agents that are significant causes of disease in developing countries.
Laura Attardi, PhD, has been promoted to associate professor of radiation oncology and of genetics, as of Feb. 1. Her research is focused on studying the p53 tumor suppressor gene, which plays a crucial role in protecting organisms from developing cancer.
David Relman, MD, has been promoted to professor of medicine (infectious diseases) and of microbiology and immunology, as of Feb. 1. His research focuses on microbial pathogenesis and human microbial ecology. He is chair of the administrative panel on biosafety at Stanford, and chief of infectious diseases at the VA-Palo Alto. Relman also directs the infectious diseases training program at the School of Medicine.
